Aspire Growth Partners »

Cytomx Therapeutics shares owned by Aspire Growth Partners

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Aspire Growth Partners from 13F filings

Historical chart of Aspire Growth Partners investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Aspire Growth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Aspire Growth Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $436k 102k 4.26
2025-09-30 $326k 102k 3.19
2025-06-30 $232k 102k 2.27

More positions owned by Aspire Growth Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Vanguard Admiral Fds 500 Val Idx Fd (VOOV)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Capital Group Core Equity Et Shs Creation Uni (CGUS)
Capital Group Dividend Value Shs Creation Uni (CGDV)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Total Stk Mkt (VTI)
Capital Group Intl Focus Eqt Shs Creation Uni (CGXU)
Alphabet Cap Stk Cl C (GOOG)
Wal-Mart Stores (WMT)
Amazon (AMZN)
International Business Machines (IBM)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Aspire Growth Partners

Top funds holding Cytomx Therapeutics

VR Adviser
FMR
Perceptive Advisors
Vanguard Group
OrbiMed Advisors
Commodore Capital
Point72 Asset Management
State Street Corporation
Balyasny Asset Management
ADAR1 Capital Management
Baker Bros. Advisors
Financial Engines Advisors L.L.C
Kynam Capital Management
Ikarian Capital
Vivo Capital

View all funds holding Cytomx Therapeutics